The New England Journal of Medicine published a report about whether the public is getting their money’s worth when it comes to publishing clinical trials. Looking at factors such as time to publication, cost of trials, publication bias and the impact of clinical and surrogate endpoints, the results are definitely something to think about. Out of 244 trials studied, larger studies focusing on clinical endpoints (rather than surrogate endpoints) and costing at least $5 million, were likely to be published within one year of the study even though only 16% of them showed a positive result. What are your thoughts regarding publication of study results?

For more information click here.

Advertisements